Gowda Guru S, Hegde Aditya, Shanbhag Vandita, Narayanaswamy Janardhanan C, Jaisoorya T S
Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, 560029, India.
Northwest Mental Health, Victoria, Australia.
Asian J Psychiatr. 2017 Feb;25:188-190. doi: 10.1016/j.ajp.2016.11.002. Epub 2016 Nov 11.
Chlorpromazine is a low potency "typical" antipsychotic agent used to treat schizophrenia. It continues to be prescribed frequently in India owing to its lower cost. There have been previous reports of ocular adverse effects with prolonged use of chlorpromazine. We report three patients who developed corneal and lenticular opacities secondary to prolonged chlorpromazine use leading to visual impairment. Early detection of ocular deposits and switching over to risperidone from chlorpromazine helped in the reversal of chlorpromazine- induced ocular side effects in one of them. The case series further adds evidence to the causative relationship between chlorpromazine and ocular side effects.
氯丙嗪是一种低效的“典型”抗精神病药物,用于治疗精神分裂症。由于成本较低,它在印度仍被频繁处方。此前已有关于长期使用氯丙嗪导致眼部不良反应的报道。我们报告了3例因长期使用氯丙嗪继发角膜和晶状体混浊导致视力损害的患者。其中1例患者早期发现眼部沉积物并从氯丙嗪改用利培酮,有助于逆转氯丙嗪引起的眼部副作用。该病例系列进一步为氯丙嗪与眼部副作用之间的因果关系提供了证据。